
PharmaNova is pleased to inform you that two of the pioneers of Nanoparticle technology are available to collaborate with your company. Dr. Michael Violante and Dr. Deepak Thassu are key Executives at our company, responsible for making your project successful, right from the start.
I will like to send to you non-confidential information, with your permission.
Please reply with your request for the documents to tom.biviano@pharmanovaco.com.
They will explain our technology and approach, and help you determine if we have synergy.
We may create synergy (or synergies for that matter) to work together if you can answer ‘yes’ to the following questions.
1: Are you looking for low cost product/formulation development?
2. Do you have poorly water soluble compounds and you need to increase bioavailability?
3. Will your business benefit from repurposing your APIs?
4. Will your API be improved and safer and less toxic with reduced excipient?
5. Are you looking for a way to develop a drug and tissue targeting approach for your APIs?
Our clients have this to say about us…
… very good to work with
… time is critical to my company… and (they) have responded very quickly
… I have an excellent relationship with PharmaNova and would not hesitate to recommend PharmaNova to others
We will have a non-confidential discussion to determine how your issues can be solved. Please respond to:
Tom.biviano@pharmanovaco.com or call 585-413-4721 x102
PharmaNova will provide services to quickly evaluate your compound.
We will do formulation testing and full reporting.
We then can do Optimization studies with full reporting.
Scale-up can then be performed.
Partnering is then accomplished to benefit both parties.
Rodney Brown
President
PharmaNova Inc. is a specialty pharma company that develops & partners new products e.g. modified-release gabapentin for menopausal hot flushes (end Phase 3, 2009) and novel nanoparticulate medicines.
View profile